Bio


Dr. Megan Lau is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. She earned her medical degree from UC San Diego, where she also completed her internal medicine residency as well as a hospice and palliative medicine fellowship. She practices as a hospitalist at Stanford Health Care and works with residents and students in clinical teaching. Her clinical interests include medical education, integrating primary palliative care within hospital medicine, and compassionate communication with both English and non-English speaking patients. Outside of medicine, she enjoys hiking, getting lost in a good book, and hosting lively dinner parties with friends.

Clinical Focus


  • Internal Medicine
  • Palliative Care
  • Palliative Medicine
  • Hospice Care
  • Medical Education
  • Hospital Medicine

Academic Appointments


  • Clinical Assistant Professor, Medicine

Boards, Advisory Committees, Professional Organizations


  • Member, American Academy of Hospice and Palliative Medicine (AAHPM) (2021 - Present)
  • Member, American Medical Association (AMA) (2022 - Present)
  • Member, American Geriatrics Society (AGS) (2023 - 2024)
  • Member, Society of Hospital Medicine (SHM) (2024 - Present)
  • Member, Society of General Internal Medicine (SGIM) (2026 - Present)

Professional Education


  • Board Certification: American Board of Internal Medicine, Hospice and Palliative Medicine (2025)
  • Fellowship, UCSD, Hospice and Palliative Medicine (2025)
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2024)
  • Residency: UCSD Internal Medicine Residency (2024) CA
  • Medical Education: University of California San Diego School of Medicine (2021) CA

All Publications


  • A Modified Delphi Process to Identify Clinical and Research Priorities for Aging Transgender Adults JOURNAL OF THE AMERICAN GERIATRICS SOCIETY Lau, M., Blumenthal, J., Karris, M. 2026

    Abstract

    Aging transgender adults experience unique medical and social challenges, but limited data exist regarding healthcare needs and priorities. Identifying these can help guide transgender-informed, patient-centered care and aging research.We employed a modified, two-round Delphi method with a consensus committee to identify clinical and research priorities for aging transgender adults. Expert panelists with experience in transgender, geriatric, and/or HIV care and research rated 15 clinical and 7 research topics using a 5-point Likert scale. Consensus was defined as > 80% of expert panelists ranking a topic as "Very important" or "Extremely important." Following Round 1, a consensus committee of older transgender adults reviewed topics and write-in suggestions and could elevate, reinstate, or add priorities by unanimous agreement. Topics selected by the committee advanced to Round 2 for expert panel ranking, followed by consensus committee review.Forty-eight expert panelists completed Round 1, and 31 completed Round 2. After Round 1, 11 clinical and 3 research topics reached consensus. Following consensus committee review, 10 clinical and 6 research priorities advanced to Round 2. After final review, the highest-ranked clinical priorities were "Provider knowledge on the unique needs of older transgender adults," "Evaluation of social isolation, loneliness, and social support networks," and "Provider/clinic knowledge of social, legal, financial, and mental health resources for transgender persons." The highest-ranked research priorities were "Clinical implications of long-term gender-affirming hormone therapy and hormone cessation," "Biologic mechanisms of hormone therapy on aging and aging outcomes," and "Health, social, and structural needs of older transgender persons."Using a community-engaged modified Delphi approach, this study identified key clinical and research priorities for older transgender adults. Findings highlight the importance of provider knowledge, social support, and addressing knowledge gaps in gender-affirming care and aging. These results provide direction for future research and best practice guidelines for this population.

    View details for DOI 10.1111/jgs.70771

    View details for Web of Science ID 001904817100001

    View details for PubMedID 42876410

  • Preventive and Sexual Health in LGBTQ+ Older Adults. Clinics in geriatric medicine Karris, M. Y., Lau, M., Blumenthal, J. 2024; 40 (2): 223-237

    Abstract

    Sexual health is an important but often overlooked health concern of LGBTQ + older adults. Multiple factors influence sexual health including intersecting identities; adverse life events; coping mechanisms; and psychological, social, and physical health domains. Thus, the use of a culturally competent and comprehensive person-centered approach to sexual health is warranted. In this review, we discuss approaches to engaging LGBTQ + older adults to ensure they are able to achieve their sexual health priorities and prevent new human immunodeficiency virus infections. We also discuss doxycycline postexposure prophylaxis to prevent other sexually transmitted infections and the impact of chemsex.

    View details for DOI 10.1016/j.cger.2023.10.002

    View details for PubMedID 38521594

  • Impact of Home-Based Pediatric Palliative Care on Hospital and Emergency Department Utilization at a Single Institution. Journal of palliative medicine Bower, K. A., Lau, M., Short, R., Lawrence, S., Beauchamp-Walters, J., Marc-Aurele, K. 2022; 25 (2): 301-306

    Abstract

    Background: There is limited data on home-based pediatric palliative care (PPC) demographics and utilization outcomes. Objective: Describe who receives home-based PPC and compare emergency department visits, hospital admissions, and hospital days admitted in the one year before and after initiation of home-based PPC. Design: Exploratory retrospective medical chart review. Settings/Subjects: Patients, from birth to their 21st birthday, who received home-based PPC during January 1, 2015 to July 31, 2016 at a single site. Measurements: Demographics and hospital utilization were extracted from the medical chart. Results:N = 154. Comparing one year before and after initiation of home-based PPC, the median number of hospitalizations decreased from 2 to 1 (p < 0.001), and the median total number of hospital days admitted decreased from 16 to 4 days (p < 0.001). Conclusions: Children enrolled in a home-based PPC program experienced a significant decrease in the number of hospital admissions and hospital days admitted.

    View details for DOI 10.1089/jpm.2021.0307

    View details for PubMedID 35119955

  • Expanding the genotypic spectrum of ACTG2-related visceral myopathy. Cold Spring Harbor molecular case studies James, K. N., Lau, M., Shayan, K., Lenberg, J., Mardach, R., Ignacio, R., Halbach, J., Choi, L., Kumar, S., Ellsworth, K. A. 2021; 7 (3)

    Abstract

    Visceral myopathies (VMs) encompass a spectrum of disorders characterized by chronic disruption of gastrointestinal function, with or without urinary system involvement. Pathogenic missense variation in smooth muscle γ-actin gene (ACTG2) is associated with autosomal dominant VM. Whole-genome sequencing of an infant presenting with chronic intestinal pseudo-obstruction revealed a homozygous 187 bp (c.589_613 + 163del188) deletion spanning the exon 6-intron 6 boundary within ACTG2 The patient's clinical course was marked by prolonged hospitalizations, multiple surgeries, and intermittent total parenteral nutrition dependence. This case supports the emerging understanding of allelic heterogeneity in ACTG2-related VM, in which both biallelic and monoallelic variants in ACTG2 are associated with gastrointestinal dysfunction of similar severity and overlapped clinical presentation. Moreover, it illustrates the clinical utility of rapid whole-genome sequencing, which can comprehensively and precisely detect different types of genomic variants including small deletions, leading to guidance of clinical care decisions.

    View details for DOI 10.1101/mcs.a006085

    View details for PubMedID 33883208

    View details for PubMedCentralID PMC8208046